share_log

和黃醫藥：截至2024年1月31日止月份之股份發行人的證券變動月報表

HUTCHMED: Monthly Return of Equity Issuer on Movements in Securities for the month ended January 31, 2024

香港交易所 ·  Feb 1 03:39
Summary by Moomoo AI
和黃醫藥（中國）有限公司於2024年2月1日向香港交易及結算所有限公司提交了最新的證券變動月報表，報告截至2024年1月31日的公司股本變動情況。報告顯示，和黃醫藥的法定/註冊股本及已發行股份在本月內均無變動，維持在1,500,000,000股，每股面值0.1美元，總股本為150,000,000美元。此外，根據2015年4月24日通過的股份期權計劃，本月底結存的股份期權數量為29,293,955，與上月相比減少了242,700，由於股份期權的行使或失效。本月內並無新股份因行使股份期權而發行，也無其他股份變動。報告由非執行董事兼公司秘書施熙德提交。
和黃醫藥（中國）有限公司於2024年2月1日向香港交易及結算所有限公司提交了最新的證券變動月報表，報告截至2024年1月31日的公司股本變動情況。報告顯示，和黃醫藥的法定/註冊股本及已發行股份在本月內均無變動，維持在1,500,000,000股，每股面值0.1美元，總股本為150,000,000美元。此外，根據2015年4月24日通過的股份期權計劃，本月底結存的股份期權數量為29,293,955，與上月相比減少了242,700，由於股份期權的行使或失效。本月內並無新股份因行使股份期權而發行，也無其他股份變動。報告由非執行董事兼公司秘書施熙德提交。
HE HUANG PHARMACEUTICAL (CHINA) CO., LTD. FILED ITS LATEST MONTHLY SECURITIES CHANGE REPORT WITH HONG KONG TRADING AND SETTLEMENT LIMITED ON FEBRUARY 1, 2024, REPORTING THE CHANGES IN THE COMPANY'S SHARE CAPITAL AS OF JANUARY 31, 2024. The report shows that the regulary/registered share capital and issued shares of Wong Pharmaceutical remained unchanged during the month at 1,500,000,000 shares with a face value of $0.1 per share and a total share capital of $150,000,000. In addition, under the stock option plan approved on April 24, 2015, the number of stock options outstanding at the end of the month was 29,293,955, a decrease of 242,700 compared to the previous month, due to the exercise or expiration of stock options. No new shares were issued during the month as a result of the exercise of share options and no other share changes. The report was submitted by the Non-Executive Director and Company Secretary Shi Xie.
HE HUANG PHARMACEUTICAL (CHINA) CO., LTD. FILED ITS LATEST MONTHLY SECURITIES CHANGE REPORT WITH HONG KONG TRADING AND SETTLEMENT LIMITED ON FEBRUARY 1, 2024, REPORTING THE CHANGES IN THE COMPANY'S SHARE CAPITAL AS OF JANUARY 31, 2024. The report shows that the regulary/registered share capital and issued shares of Wong Pharmaceutical remained unchanged during the month at 1,500,000,000 shares with a face value of $0.1 per share and a total share capital of $150,000,000. In addition, under the stock option plan approved on April 24, 2015, the number of stock options outstanding at the end of the month was 29,293,955, a decrease of 242,700 compared to the previous month, due to the exercise or expiration of stock options. No new shares were issued during the month as a result of the exercise of share options and no other share changes. The report was submitted by the Non-Executive Director and Company Secretary Shi Xie.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more